169
Views
32
CrossRef citations to date
0
Altmetric
Review

Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus

&
Pages 273-278 | Published online: 23 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yaping Wang, Yabing Mai & Weili He. (2016) A Quantitative Approach for Benefit-Risk Assessment Using Stochastic Multi-Criteria Discriminatory Method. Statistics in Biopharmaceutical Research 8:4, pages 373-378.
Read now

Articles from other publishers (31)

Kang Chen, Xingyu Li, Yuqi Shang, Daxiang Chen, Siying Qu, Jinxian Shu, Mei Zhang, Zhiying Wang, Jinmei Huang, Minhao Wu, Siqi Ming & Yongjian Wu. (2023) FGL1-LAG3 axis impairs IL-10-Producing regulatory T cells associated with Systemic lupus erythematosus disease activity. Heliyon 9:10, pages e20806.
Crossref
Saleha Dar, Sabina Koirala, Arooba Khan, Mounika Deepthi Bellary, Arya V Patel, Bejoi Mathew, Rahul Singh, Nahida Baigam, Waleed Razzaq, Zain U Abdin & Uzzam Ahmed Khawaja. (2023) A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations. Cureus.
Crossref
Dario Roccatello, Savino Sciascia, Daniela Rossi & Roberta Fenoglio. (2023) Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management. Drugs 83:2, pages 117-134.
Crossref
Chrong-Reen Wang & Hung-Wen Tsai. (2022) Autoimmune liver diseases in systemic rheumatic diseases. World Journal of Gastroenterology 28:23, pages 2527-2545.
Crossref
Robert G. Lahita & Trina Pal. 2021. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 585 589 .
José A González-Regueiro, Mariana Cruz-Contreras, Javier Merayo-Chalico, Ana Barrera-Vargas, Astrid Ruiz-Margáin, Alejandro Campos-Murguía, May Espin-Nasser, Braulio Martínez-Benítez, Victor H Méndez-Cano & Ricardo U Macías-Rodríguez. (2020) Hepatic manifestations in systemic lupus erythematosus. Lupus 29:8, pages 813-824.
Crossref
Tatiana M. Reshetnyak, Irina A. Doroshkevich, Natalia V. Seredavkina, Evgeny L. Nasonov, Igor V. Maev & Vasiliy I. Reshetnyak. (2019) The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome . International Journal of Rheumatology 2019, pages 1-18.
Crossref
Ferenc Zsila, Gergely Kohut & Tamás Beke-Somfai. (2019) Disorder-to-helix conformational conversion of the human immunomodulatory peptide LL-37 induced by antiinflammatory drugs, food dyes and some metabolites. International Journal of Biological Macromolecules 129, pages 50-60.
Crossref
Atsushi Takahashi & Hiromasa Ohira. 2019. Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases. Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases 1 22 .
Jaqueline Cristina de Amorim, Aline Kuhl Torricelli, Renan Bazuco Frittoli, Aline Tamires Lapa, Sergio San Juan Dertkigil, Fabiano Reis, Lilian TL. Costallat, Marcondes Cavalcante França Junior & Simone Appenzeller. (2018) Mimickers of neuropsychiatric manifestations in systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology 32:5, pages 623-639.
Crossref
Sang Kyu ChoiCheol Keun KimDong In JoMyung Chul LeeJee Nam KimHyun Gon ChoiDong Hyeok ShinSoon Heum Kim. (2018) Adverse Hemodynamic Effects of Nefopam in Patients Undergoing Plastic and Aesthetic Surgery: A Single-Center Retrospective Study. Archives of Aesthetic Plastic Surgery 24:1, pages 26.
Crossref
Caroline GordonMaame-Boatemaa Amissah-ArthurMary GayedSue BrownIan N. BruceDavid D’CruzBenjamin EmpsonBridget GriffithsDavid JayneMunther KhamashtaLiz LightstonePeter Norton, Yvonne Norton, Karen SchreiberDavid Isenberg. (2018) The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology 57:1, pages e1-e45.
Crossref
Germán Morís & Juan Carlos García-Moncó. 2018. CNS Infections. CNS Infections 275 300 .
Daniel J. Wallace. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology 377 390 .
Davood Rostamzadeh, Seyed Rasol Razavi, Shadi Esmaeili, Sanam Dolati, Majid Ahmahi, Sanam Sadreddini, Farhad Jadidi-Niaragh & Mehdi Yousefi. (2016) Application of nanoparticle technology in the treatment of Systemic lupus erythematous. Biomedicine & Pharmacotherapy 83, pages 1154-1163.
Crossref
Robert G. Lahita & Chengqun Shao. 2016. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 511 514 .
Atsushi Takahashi, Kazumichi Abe, Hiroshi Watanabe & Hiromasa Ohira. 2016. The Liver in Systemic Diseases. The Liver in Systemic Diseases 271 291 .
Daniel J. Wallace. 2015. Rheumatology. Rheumatology 1099 1106 .
Maryam Al Hussaini, Emad I. Hammouda & Ahmed E. Hammouda. (2014) Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role. International Journal of Clinical Pharmacy 36:4, pages 684-692.
Crossref
Wen Xiong & Robert G. Lahita. (2013) Pragmatic approaches to therapy for systemic lupus erythematosus. Nature Reviews Rheumatology 10:2, pages 97-107.
Crossref
Fernando Bessone. (2014) Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis. World Journal of Hepatology 6:6, pages 394.
Crossref
B Griffin & L Lightstone. (2013) Renoprotective strategies in lupus nephritis: beyond immunosuppression. Lupus 22:12, pages 1267-1273.
Crossref
Manuel F Ugarte-Gil & Graciela S Alarcón. (2013) Is there an effective treatment for late-onset systemic lupus erythematosus?. Aging Health 9:4, pages 437-450.
Crossref
Samuel L. Gurevitz, Jennifer A. Snyder, Eric K. Wessel, Julianne Frey & Bridget A. Williamson. (2013) Systemic Lupus Erythematosus: A Review of the Disease and Treatment Options. The Consultant Pharmacist 28:2, pages 110-121.
Crossref
Eric G. Boyce & Bryan E. Fusco. (2012) Belimumab: Review of Use in Systemic Lupus Erythematosus. Clinical Therapeutics 34:5, pages 1006-1022.
Crossref
Gabriela Schmajuk & Jinoos Yazdany. (2011) Drug Monitoring in Systemic Lupus Erythematosus: A Systematic Review. Seminars in Arthritis and Rheumatism 40:6, pages 559-575.
Crossref
E Shapira, E Proscura, B Brodsky & U Wormser. (2011) Novel peptides as potential treatment of systemic lupus erythematosus. Lupus 20:5, pages 463-472.
Crossref
W. Joseph McCune, Patricia C. Cagnoli & Tania Gonzalez-Rivera. 2011. Rheumatology. Rheumatology 1307 1316.e4 .
Olga Dvorkina & Ellen M. Ginzler. 2011. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 1045 1060 .
Joseph P. Michalski & Charles Kodner. (2010) Systemic Lupus Erythematosus: Safe and Effective Management in Primary Care. Primary Care: Clinics in Office Practice 37:4, pages 767-778.
Crossref
Y-T Wang, H-H Chou, F-F Chen, M-J Chen & Y-Y Chiou. (2016) A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: just a coincidence?. Lupus 15:4, pages 244-247.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.